Fig. 5From: MPC-n (IgG) improves long-term cognitive impairment in the mouse model of repetitive mild traumatic brain injuryMPC-n (IgG) suppresses the activation of microglia and the release of pro-inflammatory factors. A, B Immunofluorescence staining of activated microglia in the cortex and C, D hippocampus. Scale bar = 50 μm (n = 5–6). E, F Array quantification of cytokine quantification indicated the decrease of M-CSF, CXCL12, CCL2/MCP-1, IFN-γ, CCL12, and TNF-α after the treatment of MPC-n (IgG)Back to article page